Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of APOL1-mediated kidney disease
Economic impact of APOL1-mediated kidney disease on families
5 evidence topics · 6 sources
Work productivity of care-partners and caregivers of patients with FSGS
“Additionally, 14–20% of care-partners and caregivers reported moderate to severe anxiety or depression. All employed groups reported high overall work impairment (15.0–30.6%), with adult patients and their care-partners reporting high FSGS-related activity impairment (37.8%; 17.3%, respectively), absenteeism (10.4%; 6.1%) and presenteeism (21.8%; 11.6%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Work productivity and financial well-being of 674 caregivers of patients with CKD in seven countries, including the United States
“A total of 1303 patients and 674 caregivers were recruited.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Work productivity and activity impairment were greatest among dialysis patients, a trend also observed among caregivers for patients on dialysis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Caregivers for patients with CKD generally reported a higher degree of impairment than the matched general population for absenteeism (mean range 3.4–14.7% vs. 1.4–20.8%; difference: − 7.6% to 12.0%), presenteeism (mean range 28.7–41.3% vs. 8.5–19.8%; difference: 12.0–28.2%), work activities (mean range 22.5–33.6% vs. 7.8–19.1%; difference: 11.1–23.7%), non-work activities (mean range 34.5–49.8% vs. 11.2–21.0%; difference: 17.9–34.9%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The indirect burden of CKD extends beyond clinical costs to include significant financial and work productivity impacts on patients and caregivers, with greater challenges for patients on dialysis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Loss of employer-sponsored health insurance after dialysis initiation in the United States
“18,408 in-center hemodialysis and peritoneal dialysis patients employed full-time at the time of dialysis initiation, with employer-sponsored health insurance three months post-dialysis, followed for loss of employer-sponsored health insurance.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Compared to patients receiving PD, patients receiving IHD without a fistula (HR, 1.26 [95% CI, 1.18–1.36]) and with a fistula (HR, 1.14 [95% CI, 1.05–1.24]) were more likely to lose employer-sponsored health insurance.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Less than one quarter of working-age patients in the United States who began dialyzing between 1996 and 2013 were employed at dialysis initiation, and 38% of those employed six months prior to chronic dialysis were unemployed at dialysis start.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Direct and indirect costs to living kidney donors and their caregivers
“We collected cost data in the 12 mo following donation from 182 LKDs participating in the multicenter prospective Kidney Donor Outcomes Cohort (KDOC) Study.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“LKDs missed 33 072 total work hours, 40% of which were unpaid and led to $302 175 in lost wages (mean $1660). Caregivers lost $68 655 in wages (mean $377). Although some donors received financial assistance, 89% had a net financial loss in the 12-mo period, with one-third (33%) reporting a loss exceeding $2500.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Family implications of APOL1 genetic testing
“Established guidance on disclosure of genetic test results to family members (cascade testing) should be followed. This typically involves provision of support and resources to a patient for passing on information to the family (if they choose) who may then seek counseling and testing.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“What are the impacts on individuals, families, and communities of donating and not donating kidneys from individuals with high-risk APOL1 genotypes (economic, psychological, societal), including consequences of continuing dialysis?” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Apolipoprotein L1 (APOL1) renal risk variants (RRVs) contribute to the increased risk of kidney disease among Black Americans, but use of genetic testing may be limited by patient concerns regarding clinical implications and effects on family.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
APOL1-specific family cost studies
No evidence found.